METHODS: Trio (parents-proband) Whole-exome sequence(WES) and whole-genome sequencing(WGS) was carried out in this study to investigate the underlying pathogenic genetic factor of the neonate with a wide variety of clinical abnormalities.
RESULTS: No possible pathogenetic variation was detected by trio-WES, and a duplication variant in HOXA13 (c.360_377dup, p.Ala128_Ala133dup), inherited from her mother, was identified by the subsequent WGS in the proband with malnutrition, feeding difficulties, electrolyte disorders, metabolic acidosis, recurrent urinary tract infections, hydronephrosis, nephrolithiasis, abnormal ureter morphology, cholelithiasis, uterus didelphys. Sequence analysis of the variant region (exon1) indicated a high GC content of 73.92%. In addition, further enquiry of the family history revealed that 5 members of the family in 4 generations had hand and foot anomalies.
CONCLUSIONS: The neonate was diagnosed with HFGS by genetic analysis. GC content had less influence on sequence coverage in WGS than WES analysis. This was the first report of trio-WGS study for HFGS genetic diagnosis, revealed that subsequent WGS was necessary for identification of potentially pathogenic variants in unexplained genetic disorders.
方法:本研究进行了Trio(父母先证者)全外显子组测序(WES)和全基因组测序(WGS),以研究具有多种临床异常的新生儿的潜在致病遗传因素。
结果:Trio-WES未检测到可能的致病变异,和HOXA13中的重复变体(c.360_377dup,p.Ala128_Ala133dup),从她母亲那里继承下来,随后的WGS在先证者中发现营养不良,喂养困难,电解质紊乱,代谢性酸中毒,复发性尿路感染,肾积水,肾结石,输尿管形态异常,胆石症,子宫didelphys。变异区(外显子1)的序列分析表明73.92%的高GC含量。此外,对家族史的进一步调查显示,该家族4代中有5名成员有手脚异常。
结论:通过基因分析,新生儿被诊断为HFGS。与WES分析相比,GC含量对WGS中序列覆盖率的影响较小。这是用于HFGS基因诊断的Trio-WGS研究的第一份报告,揭示了随后的WGS对于鉴定无法解释的遗传疾病中的潜在致病变异是必要的。